Research study Program year 2024 Source: CMS Open Payments

1698-302-007 Ph3 Extension Study (M21-489)

ClinicalTrials.gov NCT03891446

Research payments

$441,579

37 payments

Through program year 2024, $441,579 in research payments was reported against 1698-302-007 Ph3 Extension Study (M21-489), across 37 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03891446

By program year

1 row

Year	Kind	Amount	Payments
2024	Research	$441,579	37

Breakdown

Who paid Research payments · program year 2024

AbbVie, Inc. $441,579 37 payments

Who received the money Research payments · program year 2024

Doc Trials LLC Organisation paid for research $27,086 3 payments
Emerson Clinical Research Institute Organisation paid for research $17,684 1 payment
Logan Ophthalmic Research LLC Organisation paid for research $17,684 1 payment
University of South Florida Organisation paid for research $17,684 1 payment
Vanderbilt University Medical Center Teaching hospital · TN $17,684 1 payment
Alexian Brothers Health System Organisation paid for research $17,684 1 payment
Keystone Operations LLC Organisation paid for research $17,684 1 payment
Los Angeles Vision Center INC Organisation paid for research $17,684 1 payment
Colorado Eye Institute (Dba) Organisation paid for research $17,684 1 payment
Eye Associates of North Jersey PA Organisation paid for research $17,684 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.